APO-Metaraminol metaraminol (as tartrate) 10 mg/1 mL solution for injection ampoule

Kraj: Australia

Język: angielski

Źródło: Department of Health (Therapeutic Goods Administration)

Składnik aktywny:

metaraminol tartrate, Quantity: 18.976 mg (Equivalent: metaraminol, Qty 10 mg)

Dostępny od:

Arrotex Pharmaceuticals Pty Ltd

Forma farmaceutyczna:

Injection, solution

Skład:

Excipient Ingredients: sodium metabisulfite; water for injections; sodium chloride

Droga podania:

Intravenous

Sztuk w opakowaniu:

5

Typ recepty:

(S4) Prescription Only Medicine

Wskazania:

Prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,It may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Podsumowanie produktu:

Visual Identification: clear colorless solution; Container Type: Ampoule; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Status autoryzacji:

Registered

Data autoryzacji:

2019-09-26